奥斯托邦丁作为潜在的卵巢癌诊断生物标志物
Jae-Hoon Kim1, Steven J Skates, Toshimitsu Uede
1Laboratory of Gynecologic Oncology, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA 02115, USA.
JAMA
|April 3, 2002
概括
卵巢癌的潜在生物标志物骨质,在癌细胞和患者血中发现的水平显著更高. 需要进一步的研究来探索其在早期检测和监测方面的临床实用性.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 开发新的生物标志物对于有效的卵巢癌检测和管理至关重要.
- 补充DNA (cDNA) 微阵列分析有助于识别癌细胞中过度表达的基因,如骨质疏松素.
研究的目的:
- 验证骨质疏松素作为卵巢癌的潜在生物标志物.
- 为了研究在卵巢癌组织和患者血中的骨质丁的表达水平.
主要方法:
- 利用了涉及卵巢癌细胞系,组织和患者血的实验和横截面研究.
- 使用实时聚合酶链反应 (PCR) 测量骨质素信使RNA (mRNA) 表达.
- 通过免疫组织化学评估骨质蛋白的局部化,并使用酶相关免疫测试 (ELISA) 量化血水平.
主要成果:
- 与健康对照组相比,在卵巢癌细胞系中,骨质胺mRNA的表达显著更高 (P=.03).
- 免疫组织化学分析显示,侵袭性和边缘性卵巢瘤与良性瘤和健康组织 (P=.03) 中的骨质素水平升高.
- 与健康对照组 (147.1 ng/mL),良性卵巢疾病患者 (254.4 ng/mL) 和其他妇科癌症 (260.9 ng/mL) (P<.001) 相比,卵巢癌患者 (486.5 ng/mL) 的血骨质素水平显著升高 (P<.001).
结论:
- 研究结果表明,骨质素水平与卵巢癌之间存在强烈的关联.
- 奥斯托邦丁作为卵巢癌的潜在生物标志物显示出希望.
- 建议进行进一步的研究,以确定骨质在卵巢癌管理中的临床意义.
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


